Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2026-02-28 @ 5:29 AM
Study NCT ID:
NCT03932318
Status:
WITHDRAWN
Last Update Posted:
2023-07-20
First Post:
2019-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML Patients
Sponsor:
Organization: